Demographic characterization of the population with Barrett’s esophagus in two medical centers of Bogotá, Colombia
DOI:
https://doi.org/10.22516/25007440.488Keywords:
Barrett´ s esophagus, Sex, Age distribution, Signs and symptoms, PrevalenceAbstract
Introduction: Barrett’s esophagus occurs when the stratified squamous epithelium of the esophagus changes to a specialized columnar epithelium as a result of chronic gastroesophageal reflux. Its current prevalence in Colombia is unknown and the population suffering from it has not been characterized. The present study aims to determine the main demographic characteristics of the population diagnosed with Barrett’s esophagus treated at two medical centers in Bogotá, Colombia.
Materials and methods: A multicenter cross-sectional study was conducted to assess the endoscopy and histopathology reports of 3,000 patients who underwent this procedure for any reason. A descriptive statistical analysis of the data was performed.
Results: The prevalence of Barrett’s esophagus in the sample was 0.73%. The endoscopic-histology correlation was low (28.5%). Of the diagnosed cases, the most frequent age range was 60-80 years, with an average age of 65.5 years. This condition is predominant in the female sex (63.6%), in people with a BMI over 25 kg/m², with a history of smoking, and no history of alcohol consumption. Most patients underwent endoscopy for symptoms associated with gastroesophageal reflux (50%). The length of the observed segment was not reported in most endoscopies.
Conclusions: In the medical centers included in this study, Barrett’s esophagus is a rare pathology, found predominantly in elderly women with symptoms of gastroesophageal reflux, overweight, and with a history of smoking.
Downloads
References
Spechler SJ, Souza RF. Barrett’s esophagus. N Engl J Med. 2014;371(9):836-845.
http://doi.org/10.1056/NEJMra1314704
Hani A. Esófago de Barrett: Una problemática para analizar, editorial. Rev Col Gastroenterol. 2008;23(1):1-2.
Van der Veen AH, Dees J, Blankensteijn JD, Van Blankenstein M. Adenocarcinoma in Barrett’s oesophagus: an overrated risk. Gut. 1989;30(1):14-18.
http://doi.org/10.1136/gut.30.1.14
Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365(15):1375-1383.
http://doi.org/10.1056/NEJMoa1103042
Pohl H, Pech O, Arash H, Stolte M, Manner H, May A, Kraywinkel K, Sonnenberg A, Ell C. Length of Barrett’s oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma. Gut. 2016;65(2):196-201.
http://doi.org/10.1136/gutjnl-2015-309220
Sikkema M, Looman CW, Steyerberg EW, Kerkhof M, Kastelein F, van Dekken H, van Vuuren AJ, Bode WA, van der Valk H, Ouwendijk RJ, Giard R, Lesterhuis W, Heinhuis R, Klinkenberg EC, Meijer GA, ter Borg F, Arends JW, Kolkman JJ, van Baarlen J, de Vries RA, Mulder AH, van Tilburg AJ, Offerhaus GJ, ten Kate FJ, Kusters JG, Kuipers EJ, Siersema PD. Predictors for neoplastic progression in patients with Barrett’s Esophagus: a prospective cohort study. Am J Gastroenterol. 2011;106(7):1231-8.
http://doi.org/10.1038/ajg.2011.153
Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. Am J Epidemiol. 2008;168(3):237-249.
http://doi.org/10.1093/aje/kwn121
Sierra F. Incidencia de adenocarcinoma en esófago de Barrett, Fundación Santa Fe de Bogotá, 11 años de seguimiento. Rev Col Gastroenterol. 2008;23(1):13-25.
Desai TK, Krishnan K, Samala N, Singh J, Cluley J, Perla S, Howden CW. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut. 2012;61(7):970-6.
http://doi.org/10.1136/gutjnl-2011-300730
Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, Murray LJ. Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103(13):1049-57.
http://doi.org/10.1093/jnci/djr203
Herrera JL, Monreal R, García D, González EI, Borjas OD, Maldonado HJ, González JA. Prevalencia de esófago de Barrett: estudio observacional en una clínica de gastroenterología. 2017;82(4):296-300.
https://doi.org/10.1016/j.rgmx.2017.01.006
Olmos JA, Piskorz MM, Vela MF. Revisión sobre enfermedad por reflujo gastroesofágico (ERGE). Acta Gastroenterol Latinoam. 2016;46(2):160-172.
Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology. 2002;123(2):461-467.
http://doi.org/10.1053/gast.2002.34748
Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Matthews JB, Pollock RE. Schwartz’s Principles of Surgery. Nueva York: McGraw-Hill, 9a edición; 2010.
Angarita OR, Granados CE, Ricaurte O. Frecuencia de esófago de Barrett en una serie de biopsias endoscópicas de esófago (2002-2007). Rev Col Gastroenterol. 2008;23(1):4-12.
Chacaltana A, Urday C, Ramon W, Rodríguez C, Espinoza J, Velarde H, Rodríguez I, Lucho E, Rauch E. Prevalencia, características clínico-endoscópicas y factores predictivos de Esófago de Barrett. Rev Gastroenterol Perú. 2009;29(1):24-32.
Odze RD. Gastrointestinal Pathology, An Issue of Gastroenterology Clinics (The Clinics: Internal Medicine). Filadelfia: Saunders; 2007.
Spechler SJ. Barrett esophagus and risk of esophageal cancer: a clinical review. JAMA. 2013;310(6):627-636.
http://doi.org/10.1001/jama.2013.226450
Shinkai H, Iijima K, Koike T, Abe Y, Dairaku N, Inomata Y, Kayaba S, Ishiyama F, Oikawa T, Ohyauchi M, Ito H, Asonuma S, Hoshi T, Kato K, Ohara S, Shimosegawa T. Association between the body mass index and the risk of Barrett’s esophagus in Japan. Digestion. 2014;90(1):1-9.
http://doi.org/10.1159/000357776
El-Serag HB, Kvapil P, Hacken-Bitar J, Kramer JR. Abdominal obesity and the risk of Barrett’s esophagus. Am J Gastroenterol. 2005;100(10):2151-2156.
http://doi.org/10.1111/j.1572-0241.2005.00251.x
Iyer PG, Kaul V. Barrett Esophagus. Mayo Clin Proc. 2019;94(9):1888-1901.
http://doi.org/10.1016/j.mayocp.2019.01.032
Vargas G. Prevalencia y factores de riesgo en el Hospital Nacional Arzobispo Loayza, Lima-Perú. Rev Gastroenterol. 2010;30(4):284-304.
Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, Jankowski JA, Junghard O, Lundell L, Tytgat GN, Vieth M. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131(5):1392-9.
http://doi.org/10.1053/j.gastro.2006.08.032
Csendes A, Smok G, Burdiles P, Quesada F, Huertas C, Rojas J, Korn O. Prevalence of Barrett’s esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux. Dis Esophagus. 2000;13(1):5-11.
http://doi.org/10.1046/j.1442-2050.2000.00065.x
Hongo M. Review article: Barrett’s oesophagus and carcinoma in Japan. Aliment Pharmacol Ther. 2004;20 Suppl 8:50-54.
Downloads
Published
How to Cite
Issue
Section
License
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
